Exagen (XGN) Gross Profit (2018 - 2026)

Exagen (XGN) has reported Gross Profit for 9 consecutive years, with $10.2 million the latest figure, recorded in Q1 2026.

• Gross Profit for Q1 2026 came in at $10.2 million, up 11.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.9 million (up 18.56% YoY), and the FY2025 annual result was $38.8 million, up 17.18% from the prior year.
• Gross Profit was $10.2 million for Q1 2026 at Exagen, up from $9.2 million in the prior quarter.
• Over five years, Gross Profit peaked at $10.4 million in Q2 2025 and troughed at $1.5 million in Q2 2022.
• Average Gross Profit over 5 years is $7.8 million, with a median of $8.5 million recorded in 2024.
• Year-over-year, Gross Profit plunged 79.13% in 2022 and soared 443.26% in 2023.
• Over 5 years, Gross Profit stood at $6.5 million in 2022, then rose by 24.77% to $8.1 million in 2023, then grew by 4.08% to $8.5 million in 2024, then grew by 8.6% to $9.2 million in 2025, then gained by 10.85% to $10.2 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $10.2 million in Q1 2026, $9.2 million in Q4 2025, and $10.1 million in Q3 2025.